G SCHWARTZ

733 total citations
12 papers, 380 citations indexed

About

G SCHWARTZ is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, G SCHWARTZ has authored 12 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in G SCHWARTZ's work include Blood Pressure and Hypertension Studies (5 papers), Hormonal Regulation and Hypertension (4 papers) and Adrenal Hormones and Disorders (2 papers). G SCHWARTZ is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Hormonal Regulation and Hypertension (4 papers) and Adrenal Hormones and Disorders (2 papers). G SCHWARTZ collaborates with scholars based in United States and Netherlands. G SCHWARTZ's co-authors include Dora Il’yasova, Stephen T. Turner, Gregory Reardon, E BOERWINKLE, Rhonda M. Cooper‐DeHoff, Issam Zineh, Arlene B. Chapman, John G. Gums, Yan Gong and Ali R. Djalilian and has published in prestigious journals such as American Journal of Sociology, Cardiovascular Research and American Heart Journal.

In The Last Decade

G SCHWARTZ

10 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G SCHWARTZ United States 9 107 86 78 63 53 12 380
Daria Pašalić Croatia 10 92 0.9× 55 0.6× 59 0.8× 114 1.8× 28 0.5× 30 439
Anna Bizoń Poland 14 145 1.4× 45 0.5× 29 0.4× 61 1.0× 129 2.4× 43 497
Mohammed Ashique Oman 16 69 0.6× 41 0.5× 100 1.3× 119 1.9× 31 0.6× 20 532
Masahiro Nishizumi Japan 13 142 1.3× 32 0.4× 66 0.8× 96 1.5× 30 0.6× 37 687
Hyung Joon Yoo South Korea 12 84 0.8× 40 0.5× 128 1.6× 146 2.3× 53 1.0× 16 550
Ming Ming Teh Singapore 12 56 0.5× 34 0.4× 108 1.4× 236 3.7× 17 0.3× 31 635
Jiangong Zhao China 10 30 0.3× 121 1.4× 110 1.4× 51 0.8× 13 0.2× 19 469
Metin Yıldırımkaya Türkiye 10 52 0.5× 30 0.3× 124 1.6× 38 0.6× 52 1.0× 21 350
Theodore Rozema United States 6 112 1.0× 60 0.7× 22 0.3× 17 0.3× 149 2.8× 10 382
Sung Woon Kim South Korea 17 68 0.6× 34 0.4× 184 2.4× 142 2.3× 27 0.5× 43 614

Countries citing papers authored by G SCHWARTZ

Since Specialization
Citations

This map shows the geographic impact of G SCHWARTZ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G SCHWARTZ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G SCHWARTZ more than expected).

Fields of papers citing papers by G SCHWARTZ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G SCHWARTZ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G SCHWARTZ. The network helps show where G SCHWARTZ may publish in the future.

Co-authorship network of co-authors of G SCHWARTZ

This figure shows the co-authorship network connecting the top 25 collaborators of G SCHWARTZ. A scholar is included among the top collaborators of G SCHWARTZ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G SCHWARTZ. G SCHWARTZ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Johnson, Julie A., Eric Boerwinkle, Issam Zineh, et al.. (2009). Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. American Heart Journal. 157(3). 442–449. 95 indexed citations
2.
Rule, Andrew D., Steven J. Jacobsen, G SCHWARTZ, et al.. (2006). A Comparison of Serum Creatinine–Based Methods for Identifying Chronic Kidney Disease in Hypertensive Individuals and Their Siblings. American Journal of Hypertension. 19(6). 608–614. 20 indexed citations
3.
Finkielman, Javier D., et al.. (2005). Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide. American Journal of Hypertension. 18(3). 398–402. 18 indexed citations
4.
Il’yasova, Dora & G SCHWARTZ. (2005). Cadmium and renal cancer. Toxicology and Applied Pharmacology. 207(2). 179–186. 149 indexed citations
5.
Zee, Anke H. Maitland‐van der, et al.. (2005). Demographic, Environmental, and Genetic Predictors of Metabolic Side Effects of Hydrochlorothiazide Treatment in Hypertensive Subjects. American Journal of Hypertension. 18(8). 1077–1083. 22 indexed citations
6.
SCHWARTZ, G & Gregory Reardon. (2004). A Cost-effectiveness Comparison of Bimatoprost versus Latanoprost in Patients with Glaucoma or Ocular Hypertension. Survey of Ophthalmology. 49(2). 621–623. 20 indexed citations
7.
Djalilian, Ali R., et al.. (2003). Ocular surface reconstruction: limbal stem cell transplantation. Ophthalmology Clinics of North America. 16(1). 67–77. 33 indexed citations
8.
SCHWARTZ, G. (2002). Predictive value of the aldosterone-renin ratio in screening for primary aldosteronism. American Journal of Hypertension. 15(4). A226–A226. 2 indexed citations
9.
SCHWARTZ, G. (2002). Prevalence of unrecognized primary aldosteronism in essential hypertension. American Journal of Hypertension. 15(4). A18–A18. 8 indexed citations
10.
SCHWARTZ, G, Yu Xu, Clifford R. Greyson, J. Cohen, & Lin Lü. (1996). Low-dose inotropic stimulation during left ventricular ischaemia does not worsen post-ischaemic dysfunction. Cardiovascular Research. 32(6). 1024–1037. 13 indexed citations
11.
12.
SCHWARTZ, G. (1967). La Vida: A Puerto Rican Family in the Culture of Poverty-San Juan and New York.Oscar Lewis. American Journal of Sociology. 73(3). 358–359.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daria Pašalić Breakdown of academic impact, for papers by Anna Bizoń Breakdown of academic impact, for papers by Mohammed Ashique Breakdown of academic impact, for papers by Masahiro Nishizumi Breakdown of academic impact, for papers by Hyung Joon Yoo Breakdown of academic impact, for papers by Ming Ming Teh Breakdown of academic impact, for papers by Jiangong Zhao Breakdown of academic impact, for papers by Metin Yıldırımkaya Breakdown of academic impact, for papers by Theodore Rozema Breakdown of academic impact, for papers by Sung Woon Kim
Rankless by CCL
2026